Synthesis and Characterization of a Biomimetic Formulation of Clofazimine Hydrochloride Microcrystals for Parenteral Administration
Clofazimine (CFZ) is a broad spectrum antimycobacterial agent recommended by the World Health Organization as a first line treatment for leprosy and second line treatment for multidrug resistant tuberculosis. Oral administration of CFZ leads to a red skin pigmentation side effect. Since CFZ is a wea...
Saved in:
Main Authors: | Mikhail D. Murashov (Author), Jennifer Diaz-Espinosa (Author), Vernon LaLone (Author), Joel W. Y. Tan (Author), Raluca Laza (Author), Xueding Wang (Author), Kathleen A. Stringer (Author), Gus R. Rosania (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distinguishing the Concentration- vs. Bioaccumulation-Dependent Immunological and Metabolic Effects of Clofazimine
by: Andrew R. Willmer, et al.
Published: (2023) -
An Adaptive Biosystems Engineering Approach towards Modeling the Soluble-to-Insoluble Phase Transition of Clofazimine
by: Andrew R. Willmer, et al.
Published: (2021) -
Formulation and Evaluation of Silymarin Microcrystals by In- Situ Micronization Technique
by: Ala'a Dheia Noor, et al.
Published: (2019) -
Clofazimine for the treatment of tuberculosis
by: Jacob A. M. Stadler, et al.
Published: (2023) -
Process, Physicochemical Characterization and In-Vitro Assessment of Albendazole Microcrystals
by: Vandana KR, et al.
Published: (2017)